MedTrace Logo

AMD Phenotype and Genotype Study

NCT01778491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 344

Last updated 2018-04-05

No results posted yet for this study

Summary

Background:

\- Age-related macular degeneration (AMD) is a disease that blurs the sharp vision needed for activities such as reading, sewing, and driving. It affects the macula, the center of the retina at the back of the eye, which allows a person to see fine detail. Researchers want to collect medical histories, eye exam data, and genetic information that may be associated with AMD. They want to compare this information with information collected from people without AMD.

Objectives:

\- To collect medical information and gene samples for researchers studying AMD.

Eligibility:

* Individuals between and 60 and 90 years of age who have AMD in at least one eye.
* Individuals between and 60 and 90 years of age who have no AMD in either eye.

Design:

* This study will involve one study visit. This study visit will last 6 to 8 hours.
* Participants will have the following tests and exams as part of their study visit:
* Full physical exam and medical history
* Full eye examination
* Laser scan of the eye
* Retina function test
* Vision sensitivity test
* Optional blood sample (for genetic study)
* No treatment will be provided as part of this study.

Conditions

  • Age-Related Macular Degeneration
  • AMD

Sponsors & Collaborators

  • National Eye Institute (NEI)

    lead NIH

Principal Investigators

  • Emily Y Chew, M.D. · National Eye Institute (NEI)

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-05
Primary Completion
2015-09-29
Completion
2015-09-29

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01778491 on ClinicalTrials.gov